Welcoming Dr. Roland as new PCIC Manager

Posted on Wednesday, July 13, 2022

Dr. Roland Pilgram obtained a PhD from the Technical University in Graz (Austria) in Information and Computer Engineering in 2001. During his PhD and ongoing, he was a researcher in the Special Research Center for Optimization and Control at the Institute of Physiology, Medical University Graz (Austria). From 2001 – 2012, he was a postdoctoral research assistant and lecturer at the University for Health Informatics and Technology Tyrol (UMIT; Austria). His research projects mainly involved geometric modeling of 2D, 3D and 4D anatomical objects for segmentation, registration, and analysis. From 2012 – 2013 he was the managing director of the study program in business engineering at the University of Applied Sciences in Wiener Neustadt (Austria). Dr. Pilgram moved to Montreal in 2013 and started a PhD in Neuroscience at the Montreal Neurological Institute (MNI) at McGill University. He defended his thesis “Development of methods and applications to the study of the structure, function, and functional connectivity of cortical layers” in 2020. Before coming to Ottawa, he was a Neuroscience & Neurotech Project Manager at the Research Institute McGill University Health Centre (RI-MUHC).

Dr. Pilgram has experience in pursuing and managing multifaceted research projects. His passion is the development or application of methodological & computational processing streams involving cutting-edge recording/imaging techniques, data processing toolboxes and software pipelines to explore human functioning, and more recently to investigate brain functioning using novel multimodal data alignment techniques, signal analysis and functional connectivity. His general problem-solving strategy is focusing on simple, goal-oriented solutions leading to reproducible, automatic, and robust results rather than complex workarounds. Dr. Pilgram practices and values scientific knowledge exchange, which includes open communication, teaching, and knowledge transfer within and outside the scientific community. His overall interest is translational research and innovation to improve and secure our current and future health.

Back to top